Tuberculosis Outcomes in Papua, Indonesia: The Relationship with Different Body Mass Index Characteristics between Papuan and Non-Papuan Ethnic Groups

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Kenangalem, Enny ^a,b   Waramori, Govert ^c   Pontororing, Gysje J ^a   Sandjaja, ^d   Tjitra, Emiliana ^d   Maguire, Graeme ^e,f   Kelly, Paul M ^g,h   Anstey, Nicholas M ^i,j   Ralph, Anna P ^i,j  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b District Health Authority   (Indonesia)

^c Public Health and Malaria Control Department Papua   (Indonesia)

^d NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^f JAMES COOK UNIVERSITY   (Australia)

^g Population Health Division   (Australia)

^h The Australian National University   (Australia)

ⁱ MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^j ROYAL DARWIN HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INDONESIA; INFECTION RATE; MALE; MICROSCOPY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS; WEIGHT GAIN;

BODY MASS INDEX; ETHNIC GROUPS; HEMOGLOBINS; HUMANS; INDONESIA; KAPLAN-MEIER ESTIMATE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SPUTUM; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TUBERCULOSIS; WEIGHT GAIN;

EID: 84884685150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076077     Document Type: Article

References (44)

1. Mitchison DA, (1993) Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis 147: 1062-1063.
2. Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, et al. (2009) Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 9: 162-172.
3. Rieder HL, (1996) Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis 77: 124-129.
4. World Health Organisation (2010) Treatment of tuberculosis Guidelines Fourth edition WHO/HTM/TB/2009.420 WHO, Geneva, Switzerland.
5. Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, et al. (2009) Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med 180: 273-280.
6. Visser ME, Stead MC, Walzl G, Warren R, Schomaker M, et al. (2012) Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype. PLoS ONE 7: e29588.
7. Maertzdorf J, Weiner J 3rd, Kaufmann SH, (2012) Enabling biomarkers for tuberculosis control. Int J Tuberc Lung Dis 16: 1140-1148.
8. Dominguez-Castellano A, Muniain MA, Rodriguez-Bano J, Garcia M, Rios MJ, et al. (2003) Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis 7: 432-438.
9. Guler M, Unsal E, Dursun B, Aydln O, Capan N, (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract 61: 231-235.
10. Telzak EE, Fazal BA, Pollard CL, Turett GS, Justman JE, et al. (1997) Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis 25: 666-670.
11. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, (2009) Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Respirology 14: 1012-1019.
12. Khan A, Sterling TR, Reves R, Vernon A, Horsburgh CR, (2006) Lack of weight gain and relapse risk in a large tuberculosis treatment trial. Am J Respir Crit Care Med 174: 344-348.
13. Yew WW, Leung CC, (2006) Prognostic significance of early weight gain in underweight patients with tuberculosis. Am J Respir Crit Care Med 174: 236-237.
14. Hoa NB, Lauritsen JM, Rieder HL, (2012) Changes in body weight and tuberculosis treatment outcome in Viet Nam. Int J Tuberc Lung Dis 1: 61-66.
15. Bernabe-Ortiz A, Carcamo CP, Sanchez JF, Rios J, (2011) Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis. PLoS ONE 6: e18474.
16. Vasantha M, Gopi PG, Subramani R, (2009) Weight gain in patients with tuberculosis treated under directly observed treatment short-course (DOTS). Indian J Tuberc 56: 5-9.
17. Krapp F, Veliz JC, Cornejo E, Gotuzzo E, Seas C, (2008) Bodyweight gain to predict treatment outcome in patients with pulmonary tuberculosis in Peru. Int J Tuberc Lung Dis 12: 1153-1159.
18. Martins N, Morris P, Kelly PM, (2009) Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ 339: b4248.
19. Sinclair D, Abba K, Grobler L, Sudarsanam TD (2011) Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev: CD006086.
20. Cegielski JP, McMurray DN, (2004) The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 8: 286-298.
21. World Health Organization (1999) Management of severe malnutrition: a manual for physicians and other senior health workers. In: WHO Library Cataloguing in Publication Data G, editor. Geneva.
22. World Health Organisation (2006) Global Database on body mass index: Body mass index classification. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.vAccessed 2012 Dec 5.
23. World Health Organisaion Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
24. Chen X, Wang Y, (2010) Commentary: optimal body mass index cut points. Int J Epidemiol 39: 1045-1047.
25. Brian G, Ramke J, Page A, Maher L, Szetu J, et al. (2011) The association of diabetes and BMI among Melanesian and Indian Fijians aged >/ = 40 years. Br J Nutr 105: 1539-1545.
26. Brian G, Ramke J, Maher L, Page A, Fischer-Harder K, et al. (2011) Body mass index among Melanesian and Indian Fijians aged >/ = 40 years living in Fiji. Asia Pac J Public Health 23: 34-43.
27. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, et al. (1996) How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 143: 228-239.
28. Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, et al. (2013) L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS ONE accepted.
29. Ralph AP, Yeo TW, Salome CM, Waramori G, Pontororing GJ, et al. (2013) Impaired Pulmonary Nitric Oxide Bioavailability in Pulmonary Tuberculosis: Association with Disease Severity and Delayed Mycobacterial Clearance with Treatment. J Infect Dis.
30. Ardian M, Meokbun E, Siburian L, Malonda E, Waramori G, et al. (2007) A public-private partnership for TB control in Timika, Papua Province, Indonesia. Int J Tuberc Lung Dis 11: 1101-1107.
31. World Health Organisation (2002) Operational guide for the for national tuberculosis programs on the introduction and use of fixed-dose combination drugs. WHO/CDS/TB/2002.308.
32. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, et al. (2007) Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest 132: 1591-1598.
33. Maguire GP, Anstey NM, Ardian M, Waramori G, Tjitra E, et al. (2009) Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting. Int J Tuberc Lung Dis 13: 1500-1506.
34. Ralph AP, Ardian M, Wiguna A, Maguire GP, Becker NG, et al. (2010) A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis. Thorax 65: 863-869.
35. Handojo T, Anstey N, Kelly P, Pain M, Kenangalem E, et al. (2006) Normal spirometry, gas transfer and lung volume values in Papua, Indonesia. Southeast Asian J Trop Med Public Health 37: 571-577.
36. American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117.
37. Pontororing GJ, Kenangalem E, Lolong DB, Waramori G, Sandjaja, et al, (2010) The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infect Dis 10: 362.
38. World Health Organisation (2006) Global Database on body mass index: Body mass index classification. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
39. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
40. Silva CL, Faccioli LH, (1988) Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria. Infect Immun 56: 3067-3071.
41. Andrade Junior DR, Santos SA, Castro I, Andrade DR, (2008) Correlation between serum tumor necrosis factor alpha levels and clinical severity of tuberculosis. Braz J Infect Dis 12: 226-233.
42. Macallan DC, McNurlan MA, Kurpad AV, de Souza G, Shetty PS, et al. (1998) Whole body protein metabolism in human pulmonary tuberculosis and undernutrition: evidence for anabolic block in tuberculosis. Clin Sci (Lond) 94: 321-331.
43. Van Lettow M, Kumwenda JJ, Harries AD, Whalen CC, Taha TE, et al. (2004) Malnutrition and the severity of lung disease in adults with pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 8: 211-217.
44. Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, et al. (2012) The anaemia of Plasmodium vivax malaria. Malar J 11: 135.